[breadcrumb_custom]

Tag: NYSE:CVS

Markets

CVS Stock: CVS Health Corporation (NYSE:CVS) Is Still Worth a Bite

CVS Health Corporation (NYSE:CVS) has a beta of 0.81, a 12-month trailing P/E ratio of 15.20, and a growth ratio of 3.80. The stock’s Relative

Markets

Is CVS Health Corporation (NYSE:CVS) Still Worth A Bite?

CVS Health Corporation (NYSE:CVS) Relative Strength Index (RSI) is 58.50, with weekly volatility at 1.30% and ATR at 1.60. The CVS stock’s 52-week price range

Industry

CVS Health Corporation (CVS) price slipped close to $85.87 early on Tuesday: What’s Next?

CVS Health Corporation (NYSE:CVS) previous close was $86.44 while the outstanding shares total 1.31B. The firm has a beta of 0.81, a 12-month trailing P/E

Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.

Quick Links

About Us

Our Team

Disclaimer

Tag: NYSE:CVS

CVS Stock: CVS Health Corporation (NYSE:CVS) Is Still Worth a Bite

Is CVS Health Corporation (NYSE:CVS) Still Worth A Bite?

CVS Health Corporation (CVS) price slipped close to $85.87 early on Tuesday: What’s Next?

Quick Links

Categories